glucagon receptor – perVial.com

Posted on September 24, 2026 by pervial

Retatrutide in Liver Disease Research: Evidence for Hepatic Fat Reduction

3D visualization of hepatocyte cells clearing intracellular lipid droplets during metabolic liver disease research.

Retatrutide in liver disease research shows remarkable reductions in hepatic fat. Clinical trials reveal triple GIP/GLP-1/glucagon receptor agonism resolve

Read more Retatrutide in Liver Disease Research: Evidence for Hepatic Fat Reduction

Posted on September 5, 2026 by pervial

Retatrutide vs. Tirzepatide: How Triple Agonism Compares to Dual Agonism

3D scientific illustration of a multi-receptor agonist interacting with GLP-1, GIP, and glucagon receptors.

This comparative review examines retatrutide and tirzepatide, evaluating how retatrutide’s triple-receptor agonism (GLP-1, GIP, and glucagon) differs mecha

Read more Retatrutide vs. Tirzepatide: How Triple Agonism Compares to Dual Agonism